Markt oder Branche auswählen:
Chart-Typ:
Zeitraum:
| Reliance Industries, Samsung C&T sign $3 billion green ammonia supply deal | Reliance Industries has signed a 15-year green ammonia supply agreement with Samsung C&T Corp., marking one of the largest long-term offtake deals globally. India Reliance Industries, India's largest... ► Artikel lesen |
| Smt. Nita M. Ambani, Founder and Chairperson of Reliance Foundation, Conferred Prestigious KISS Humanitarian Award 2025 | BHUBANESWAR, India, March 18, 2026 /PRNewswire/ -- Smt. Nita M. Ambani, Founder and Chairperson of Reliance Foundation, was conferred the prestigious KISS Humanitarian Award 2025 at the Kalinga... ► Artikel lesen |
| Reliance Industries Reports Higher Q3 FY26 Profit On Revenue Growth | MUMBAI (dpa-AFX) - Reliance Industries Limited (RELIANCE.NS) on Friday reported a steady financial performance for the third quarter ended December 31, 2025, supported by growth across its digital... ► Artikel lesen |
| Takeda's Zasocitinib Shows Rapid, Durable Skin Clearance In Phase 3 Psoriasis Trials | HONG KONG (dpa-AFX) - Takeda (TAK) announced new data from two pivotal Phase 3 studies of zasocitinib (TAK-279), its next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor... ► Artikel lesen |
| EQS-Adhoc: Takeda Pharmaceutical Company Limited: Takeda Announces Next Steps in its Transformation to Strengthen Competitiveness and Accelerate Future Growth Outlook | EQS-Ad-hoc: Takeda Pharmaceutical Company Limited / Key word(s): Other
Takeda Pharmaceutical Company Limited: Takeda Announces Next Steps in its Transformation to Strengthen Competitiveness... ► Artikel lesen |
| Takeda, Protagonist Win FDA Priority Review For Rusfertide In Polycythemia Vera | TOKYO (dpa-AFX) - Takeda Pharmaceutical Company Limited (TAK) and Protagonist Therapeutics, Inc. (PTGX) said Monday the U.S. Food and Drug Administration has accepted the New Drug Application... ► Artikel lesen |
| Takeda Wins FDA Priority Review For Narcolepsy Drug Oveporexton | TOKYO (dpa-AFX) - Takeda Pharmaceutical Company Limited (TAK) said Tuesday that the U.S. Food and Drug Administration has accepted its new drug application for oveporexton and granted Priority... ► Artikel lesen |
| Heidelberg Pharma erhält Meilensteinzahlung von Takeda | Die Heidelberg Pharma AG hat im Rahmen einer bestehenden Lizenzvereinbarung eine Meilensteinzahlung von Takeda erhalten. Die Zahlung wurde mit der Dosierung des ersten Patienten in einer klinischen... ► Artikel lesen |
| EQS-News: Heidelberg Pharma AG: Heidelberg Pharma erhält Meilensteinzahlung des Partners Takeda | EQS-News: Heidelberg Pharma AG
/ Schlagwort(e): Sonstiges
Heidelberg Pharma erhält Meilensteinzahlung des Partners Takeda
29.01.2026 / 13:27 CET/CEST
Für den Inhalt... ► Artikel lesen |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.